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General Considerations.
NMR spectra were acquired on a Bruker AC-300 instrument at 300 and 75.5 MHz for 1 H and 13 C NMR, respectively. Chemical shifts (δ) are reported in parts per million relative to residual solvent signals (CDCl 3 , 7.26 ppm for 1 H NMR and 77.0 ppm for 13 C NMR spectra;
MeOH-d 4 3,31 ppm for 1 H NMR and 49.0 ppm for 13 C NMR). 13 C NMR spectra were acquired on a broad-band decoupled mode. Optical rotations were measured on a PerkinElmer 241 polarimeter. Mass spectra (MS) were obtained by ESI or FAB+ (matrix: m-NBA) ionization mode. High resolution mass spectra (HRMS) were performed by ESI ionization mode using a time of-flight (TOF) mass analyzer or FAB+ ionization mode. Analytical thin layer chromatography (TLC) was performed using precoated aluminum-packed plates (Merck Kieselgel 60 F254) and visualized by ultraviolet irradiation or phosphomolybdic acid dip. Flash column chromatography was performed using silica gel (230−400 mesh). All reactions were carried out in anhydrous solvents. THF and CH 2 Cl 2 were dried with molecular sieves.
Commercially available starting materials were used without purification.
Sulfinimine 3 was prepared from 2-bromobenzaldehyde and (R)-tertbutanesulfinamide, according to the known literature procedure. 1 The characterization was effected by comparison of its physical and spectroscopic data with those reported. 2
Radical Addition. General procedure
To a solution of sulfinimine 3 (0.2 mmol) in DCM (3 mL, 0.04M), under argon atmosphere, was added BF 3 ·OEt 2 (0.42 mmol, 2.1 equiv). After 5 min under stirring, the mixture was cooled to -78 °C and then, the alkyl iodide (2.0 mmol, 10 equiv), tributyltin hydride (0.5 mmol, 2.5 equiv), triethylborane (0.5 mmol, 1M hexane, 2.5 equiv) and O 2 (5 mL, via syringe) were added in this order. Successive additions of triethylborane (0.25 mmol, 1M hexane) and O 2 (5 mL, via syringe) were added every 1 or 1.5 hour until the imine disappearance (TLC). Then, the reaction was treated with aq. NaHCO 3 solution. The aqueous phase was extracted with DCM (3x5mL). The organic extracts were washed with brine and dried over MgSO 4 . The solvent was removed under reduced pressure and the residue purified by flash chromatography on silica gel:KF 0, 140.5, 133.3, 129.5, 129.0, 128.8, 128.0, 127.8, 127.4, 124.0, 61.2, 56.1, 22.7 
(S,R S )-N-{[2-Bromophenyl][3-[(tert-butyldimethylsilyloxy)methyl]phenyl}methyl-2-methylpropane-2-sulfinamide (4f).
To a solution of sulfinimine 3 (0.16 mmol) in THF (1 mL) was added . 1 H NMR (300 MHz, CDCl 3 ) δ 7.56 (dd, J = 7.7, 1.8 Hz, 1H), 7.49 (dd, J = 7.8, 1.7 Hz, 1H), 7.32-7.20 (m, 4H), 7.19-7.13 (m, 1H), 7.07 (dt, J = 7.5, 1.8 Hz, 1H), 6.06 (s, 1H), 4.64 (s, 2H), 3.65 (s, 1H), 1.19 (s, 9H), 0.85 (s, 9H), 0.00 (s, 6H). 13 C NMR (75 MHz) δ 142. 1, 141.0, 140.5, 133.3, 129.6, 129.0, 128.7, 127.5, 126.6, 125.6, 125.2, 124.0, 64.7, 61.0, 56.0, 26.0, 22.7, 18.4, -5.3 1, 138.3, 133.9, 133.2, 129.4, 128.9, 128.2, 128.8, 127.6, 123.4, 77.4, 55.6, 26.6, 22.5 4, 140.1, 133.3, 129.2, 128.9, 127.6, 123.4, 81.8, 56.0, 55.4, 41.9, 28.1, 22.8 8 Zn dust, <10µ (2.5 g). Zn activation was carried out by successive washes with an aqueous solution of HCl (5%, 3 x 3mL), H 2 O (3 x 3mL), acetone (3 x 3 mL) and dry Et 2 O (3 x 3 mL). 8, 133.4, 131.4, 129.6, 128.5, 123.4, 117.4, 57.5, 50.4, 22.4 According to the known procedure, 12 to a solution of (
in THF (1 mL) was added BH 3 .THF (0.6 mmol, 1 M in THF). The solution was heated to reflux 24 h and then, the solution was cooled to room temperature and water was slowly added until the evolution of hydrogen subsided. Then, MeOH (200 µl) and conc. H 2 SO 4 (100 µl) were added to fully decomplex the aminoborane. The solution was stirred for 10 min, basified (10% NaOH) and extracted with 
(R,S S )-3-Cyclohexyl-2,3-dihydrobenzo[d]isothiazole-1-oxide (5c).
Following the above general procedure, compound was obtained as unique 
(R,S S )-3-(tert-Butyl)-2,3-dihydrobenzo[d]isothiazole-1-oxide (5d).
Following the above general procedure, compound 5d was obtained as the sole diastereomer from sulfinamide 4d (0.45 mmol). Chromatography: n- 
(S,S S )-3-[(tert-Butyldimethylsilyloxy)methyl]phenyl-2,3-dihydrobenzo[d]isothiazole-1-oxide (5f).
Following the above general procedure, compound 5f was obtained as the sole diastereomer from sulfinamide 4f (0.45 mmol). 142.8, 142.6, 139.2, 131.7, 128.9, 126.4, 125.4, 124.6, 124.3, 68.8, 64.6, 25.9, 18.4, -5.3 . 6, 144.6, 137.9, 133.7, 131.6, 129.8, 128.8, 128.5, 124.5, 123.3, 61.9, 23.3,-1.9, -2.6 2, 135.8, 133.1, 129.3, 124.3, 121.4, 63.3, 32.8, 20.1, 15.4 0, 135.8, 133.0, 129.2, 124.4, 121.4, 62.9, 42.7, 30.7, 26.4, 25.9, 25.8, 25.8 1, 136.1, 132.3, 129.3, 126.0, 121.6, 67.4, 36.7, 26.6 8, 138.7, 134.8, 133.4, 129.5, 129.3, 129.1, 127.6, 125.4, 121.2, 61.4 8, 139.9, 138.6, 134.9, 133.3, 129.5, 129.2, 126.7, 126.2, 125.4, 125.1, 121.1, 64.5, 61,4, 25.9, 18,4, -5,27 156.7, 137.3, 136.4, 133.2, 129.8, 124.6, 121.5, 80.4, 58.3, 44.8, 28.3 
MS (ESI+)

(S,S S )-tert-Butyl 2-(1-oxide-2,3-dihydrobenzo[d]isothiazol-3-yl)acetate (5h).
